NEW YORK (GenomeWeb News) – Beckman Coulter today said it will buy the flow cytometry business of Dako for an undisclosed sum.
Included in the acquisition are Dako’s MoFlo XDP cell sorter and the CyAn research flow cytometer.
Beckman President and CEO Scott Garrett said the addition of these tools and assets to its flow cytometry line allows it to offer “a more comprehensive range of research solutions to our customers.”
Dako’s flow cytometry arm employs nearly 200 people, including research, sales and marketing, manufacturing, and administrative staffers.
The transaction is expected to close by the end of the year.
Patrik Dahlen, Dako’s CEO, said selling the flow cytometry business to Beckman Coulter “reinforces our strategic intent to create a more focused business in anatomic pathology and tissue-based cancer diagnostics."